Skip to content

Lime Powder Regimen (LPR) for Prevention of Renal Stone Recurrence

Lime Powder Regimen Supplement Alleviates Urinary Metabolic Abnormalities to Prevent Urolithiasis Recurrence.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03258190
Enrollment
137
Registered
2017-08-23
Start date
2014-07-01
Completion date
2018-06-30
Last updated
2019-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Keywords

Urolithiasis, Recurrence, Citrate, Antioxidants, Lime Powder Regimen

Brief summary

Lime powder regimen (LPR) is a lime-derived composition enriches with citrate/citric acid and potassium. LPR was invented to treat the renal stone patients with high risk of stone recurrence after stone removal. LPR should have equal or higher efficacy and lower adverse effect than current standard medicine.

Detailed description

Lime powder regimen (LPR) is a mixture of lime-derive component with adjuvants containing high concentration of citrate, and moderate amount of potassium, magnesium and antioxidants. LPR was tested and verified to be very less toxic in cell culture and animal models. The clinical trial phase II showed that LPR reduced urinary metabolic abnormalities that enhance stone formation, such as hypocitraturia, hypokaliuria and acidified urine. Adverse effect of LPR was very low.

Interventions

DRUGLime Powder Regimen

LPR and placebo were randomly given to subjects for 6 months

Sponsors

Sanpasitthiprasong Hospital
CollaboratorOTHER_GOV
Burapha University
CollaboratorOTHER
Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

LPR and Placebo were prepared in the same containers with code that was provided by investigators

Intervention model description

Randomized control trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Renal stone patients who were identified and stone was removed by surgical method.

Exclusion criteria

* Chronic kidney disease, chronic liver disease, history of coronary artery disease, or person who takes any medication that alters urinary metabolic profiles

Design outcomes

Primary

MeasureTime frameDescription
Renal stone recurrence6 monthsThe stone recurrence after surgical removal of stone that can be detected by CT scan

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026